Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Madrigal Pharmaceuticals (MDGL) Q1 2025 Earnings
MDGL
26
Feb
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-7.54
-5.93
-4.32
-2.71
Details
Expected EPS
-3.919511
Actual EPS
-2.71
Surprise EPS
1.21
Surprise Percent
+30.86%
Description
Madrigal Pharmaceuticals (MDGL) has reported earnings of -2.71 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login